Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chunyangzhengqi capsule for prevention and control of chemotherapy-induced gastrointestinal reactions
ChiCTR1800017852Phase 4Recruiting
- Sponsor
- Beijing Shijitan Hospital
- Start
- Aug 2018
- Countries
- 1
01
Overview
Phase 4 trial of chunyangzhengqi in chemotherapy-induced nausea and vomiting (CINV) and chemotherapy-induced gastrointestinal toxicity (2 arms), sponsored by Beijing Shijitan Hospital. Primary endpoint: Symptoms grade of nausea and emesis. Started Aug 2018; status: recruiting.
02
Drugs
chunyangzhengqi
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)chemotherapy-induced gastrointestinal toxicity
Beyond the preview
Go deeper on ChiCTR1800017852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017852.